这篇2018年发表的Molecular Medicine Reports 期刊,主要由Liyan Du , Xiaomei Li , Linhong Zhen , Weiling Chen , Lingguang Mu , Yang Zhang , Ailin Song共同完成,所有作者来自河北省邢台市邢台市第一医院乳腺外科,2024年9月论文被扒出图片重复多人论文而被质疑;昨天论文已被撤回
论文信息
标题:Everolimus inhibits breast cancer cell growth through PI3K/AKT/mTOR signaling pathway
作者:Liyan Du, Xiaomei Li, Linhong Zhen, Weiling Chen, Lingguang Mu, Yang Zhang, Ailin Song
期刊:Mol Med Rep
发表日期:2018年5月;电子版发表于2018年3月16日
DOI:10.3892/mmr.2018.8769
PMID:29568883
质疑内容
#1
图 4A、C、E 来自“ARHGAP1 过表达抑制 C-33A 和 SiHa 细胞系的增殖、迁移和侵袭”(Li 等人,2017 年doi: 10.2147/ott.s112223)。
图 2D 来自“长链非编码 RNA-NEAT1 通过调节宫颈癌中的 miR-124/NF-κB 通路促进细胞迁移和侵袭”(Shen et al 2020 doi: 10.2147/ott.s220306)。
Fig 3E. 图 3E.
图 6d 来自“Arhgap6 对宫颈癌细胞的抑制作用”(Li 等人,2016 年doi: 10.1007/s13277-015-4502-z)。
#2
图 5A、C、E 来自“ARHGAP1 过表达抑制 C-33A 和 SiHa 细胞系的增殖、迁移和侵袭”(Li 等人,2017 年)doi: 10.2147/ott.s112223 。
图 2C 来自“长链非编码 RNA-NEAT1 通过调节宫颈癌中的 miR-124/NF-κB 通路促进细胞迁移和侵袭”(Shen et al 2020)doi: 10.2147/ott.s220306。
Fig 3E,F. 图 3E,F.
图 7d 来自“Arhgap6 对宫颈癌细胞的抑制作用”(Li 等人,2016 年)doi: 10.1007/s13277-015-4502-z。
撤回
Following the publication of this paper, it was drawn to the Editors’ attention by a concerned reader that the Transwell migration and invasion assay data shown in Fig. 3E and F on p. 7166 were strikingly similar to data appearing in different form in other articles written by different authors at different research institutes that had already been published elsewhere prior to the submission of this paper to Molecular Medicine Reports. In view of the fact that the abovementioned data had already apparently been published previously, the Editor of Molecular Medicine Reports has decided that this paper should be retracted from the Journal. The authors were asked for an explanation to account for these concerns, but the Editorial Office did not receive a reply. The Editor apologizes to the readership for any inconvenience caused.
END
Don't be ashamed
专注于国内论文质疑报道
欢迎投稿联系